Overview

Efficacy of Protracted Temozolomide in Patients With Progressive High Grade Glioma

Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy of temozolomide on a protracted schedule, after standard 5-day temozolomide regimen in patients with recurrent or progressive high grade glioma.
Phase:
Phase 2
Details
Lead Sponsor:
Marmara University
Collaborator:
Schering-Plough
Treatments:
Dacarbazine
Temozolomide